Advertisement

Topics

Search Results for "Demodex And Psoriasis"

00:40 EST 12th February 2016 | BioPortfolio

Matching Channels

Psoriasis and Scaling Diseases

C5a R Antagonists

The interaction of complement C5a and its receptor for the treatment of inflammatory diseases include rheumatoid arthritis, systemic lupus erythematosus, asthma, wet age-related macular degeneration...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Phosphodiesterase 4 PDE 4 Inhibitors

Phosphodiesterase 4 (PDE-4) inhibitors have attracted considerable interest as potential therapeutic agents for diseases including chronic obstructive pulmonary disease. PDE-4 inhibitors are known to ...

Interleukin 17 IL 17R IL 17

The IL-17 family consists of six ligands, A-F. IL-17 was originally thought to signal via the classic receptor IL-17R, but IL17 stimulates a receptor complex that consists of the subunits IL-17RA and ...

Matching News

Got psoriasis? Get healthier with the National Psoriasis Foundation

This August, the National Psoriasis Foundation encourages people with psoriatic disease and those who love them to get healthier with our Psoriasis Awareness Month Wellness Challenge. If you have psor...

Psoriasis Linked to Higher Risk of Depression

THURSDAY, Aug. 20, 2015 -- People with psoriasis may be twice as likely to experience depression as those without the common skin condition, regardless of its severity, a new study suggests. "Psoriasi...

Medical News Today: Psoriasis patients at increased risk for depression

A major study in the US finds that psoriasis and depression are linked, but the degree of psoriasis does not imply more severe depression.

Synthetic biology: Designer cells block psoriasis

Engineered cells with synthetic gene circuits can detect and respond to disease biomarkers. These could one day help to treat psoriasis, a chronic inflammatory skin disorder.Clinical trials have shown...

Worse Psoriasis, Less Healthy Arteries, Study Finds

THURSDAY, Oct. 8, 2015 -- The skin disorder psoriasis appears linked with artery inflammation, raising the odds for heart disease, a new study says. "As the amount of psoriasis increases, the amount o...

From Psoriasis to PsA: Who and Why? (CME/CE)

(MedPage Today) -- Study shows high annual incidence of arthritis in patients with psoriasis

Activating CARD14 Mutations Are Associated With Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris

Pfizer’s Xeljanz denied plaque psoriasis indication by FDA

The FDA has rejected the indication expansion of Pfizer’s Xeljanz (tofacitinib) for treatment of moderate to severe cases of plaque psoriasis. The New York drugmaker received a complete respons...

Matching PubMed Articles

Demodex mites as potential etiological factor in chalazion - a study in Poland.

The aim of the study was to investigate the presence of Demodex in the hair follicles of eyelashes and their potential participation in the aetiology of chalazion in patients in Poland. The study of t...

Psoriasis and polycystic ovary syndrome: a new link in different phenotypes.

Women affected by PCOS and psoriasis are more likely to have insulin-resistance, hyperinsulinemia, reduced HDL cholesterol levels and a more severe degree of skin disease than those with psoriasis alo...

Sterile Corneal Infiltrates Secondary to Psoriasis Exacerbations: Topical Tacrolimus as an Alternative Treatment Option.

Psoriasis is a common chronic inflammatory skin disease. Ocular manifestations, which occur in 10% to 20% of cases of psoriasis, are usually bilateral and often present during an exacerbation of the p...

IκBζ: A key protein in the pathogenesis of psoriasis.

Psoriasis is an immune-mediated chronic inflammatory skin disease with a complex etiology. The proinflammatory cytokine IL-17A is known to play key role in the pathogenesis of psoriasis, and recently ...

Metabolic syndrome in psoriasis patients. Residual inflammation and pro-inflammatory IL17 signaling reduce length of remission. A follow-up study.

Psoriasis, a recurrent inflammatory skin condition, has been associated with metabolic syndrome (MS) and obesity. In psoriasis, obesity is closely related with hypoadiponectinemia and hyperleptinemia ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement